SCHEMBL19786588

SCHEMBL19786588

c1ccc(-n2c3ccccc3c3c4c5ccc6ccccc6c5oc4c4ccccc4c32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
ATM Q13315 1/20 0.40
ALDH1A1 P00352 4/20 0.39
HSD17B10 Q99714 3/20 0.39
TSHR P16473 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
BRCA1 P38398 1/20 0.39
HPGD P15428 4/20 0.35
CYP1A1 P04798 3/20 0.35
CYP1A2 P05177 3/20 0.35
CYP1B1 Q16678 3/20 0.35
ABCG2 Q9UNQ0 2/20 0.35
MAPT P10636 2/20 0.35
PRKDC P78527 2/20 0.35
PDE5A O76074 1/20 0.35
TP53 P04637 1/20 0.35
ABCB1 P08183 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22133366 0.90 CYP1A1 (0.39) KDM4EALDH1A1HSD17B10TSHRKMT2A
SCHEMBL23733371 0.86 KDM4E (0.49) KDM4EL3MBTL1ATMALDH1A1HSD17B10
SCHEMBL22483478 0.85 KDM4E (0.47) KDM4EL3MBTL1ATMALDH1A1HSD17B10
SCHEMBL19786324 0.83 CYP1A1 (0.36) KDM4EL3MBTL1ALDH1A1HSD17B10TSHR
SCHEMBL19786322 0.81 MEN1 (0.35) KDM4EATMALDH1A1HSD17B10TSHR
SCHEMBL17451675 0.81 KDM4E (0.44) KDM4EL3MBTL1ATMALDH1A1HSD17B10
SCHEMBL20311899 0.80 L3MBTL1 (0.47) KDM4EL3MBTL1ATMALDH1A1HSD17B10
SCHEMBL19786513 0.80 KDM4E (0.47) KDM4EL3MBTL1ATMALDH1A1HSD17B10
SCHEMBL19786325 0.80 ALDH1A1 (0.41) KDM4EL3MBTL1ATMALDH1A1HSD17B10
SCHEMBL19786331 0.80 HSD17B10 (0.36) KDM4EALDH1A1HSD17B10TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 KDM4E 442/4885L3MBTL1 1707/4885ATM 3467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.